Enhancing cognitive training effects in Alzheimer’s disease: rTMS as an add-on treatment

The treatment of Alzheimer’s disease (AD) in the field of non-pharmacological interventions is a challenging issue, given the limited benefits of the available drugs. Cognitive training (CT) represents a commonly recommended strategy in AD. Recently, repetitive transcranial magnetic stimulation (rTM...

Full description

Saved in:
Bibliographic Details
Published inBrain stimulation Vol. 13; no. 6; pp. 1655 - 1664
Main Authors Bagattini, Chiara, Zanni, Mara, Barocco, Federica, Caffarra, Paolo, Brignani, Debora, Miniussi, Carlo, Defanti, Carlo Alberto
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.11.2020
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The treatment of Alzheimer’s disease (AD) in the field of non-pharmacological interventions is a challenging issue, given the limited benefits of the available drugs. Cognitive training (CT) represents a commonly recommended strategy in AD. Recently, repetitive transcranial magnetic stimulation (rTMS) has gained increasing attention as a promising therapeutic tool for the treatment of AD, given its ability of enhancing neuroplasticity. In the present randomized, double-blind, sham-controlled study, we aimed at investigating the add-on effect of a high frequency rTMS protocol applied over the left dorsolateral prefrontal cortex (DLPFC) combined with a face-name associative memory CT in the continuum of AD pathology. Fifty patients from a very early to a moderate phase of dementia were randomly assigned to one of two groups: CT plus real rTMS or CT plus placebo rTMS. The results showed that the improvement in the trained associative memory induced with rTMS was superior to that obtained with CT alone. Interestingly, the extent of the additional improvement was affected by disease severity and levels of education, with less impaired and more educated patients showing a greater benefit. When testing for generalization to non-trained cognitive functions, results indicated that patients in CT-real group showed also a greater improvement in visuospatial reasoning than those in the CT-sham group. Interestingly, this improvement persisted over 12 weeks after treatment beginning. The present study provides important hints on the promising therapeutic use of rTMS in AD. •rTMS enhanced the effect of face-name associative memory cognitive training.•The add-on rTMS effect was influenced by disease severity and education.•rTMS amelioration generalized to visuospatial reasoning.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-News-1
ObjectType-Feature-3
content type line 23
ISSN:1935-861X
1876-4754
DOI:10.1016/j.brs.2020.09.010